Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2003
08/21/2003CA2476126A1 Shark cartilage extracts and use thereof for immunomodulation
08/21/2003CA2476000A1 Methods and compositions for treating hyperproliferative conditions
08/21/2003CA2475928A1 Inhibition of lung metastases by aerosol delivery of p53 gene and anti-cancer compounds
08/21/2003CA2475838A1 Cytotoxic t-cell epitopes from chlamydia
08/21/2003CA2475708A1 Nicotinamide derivatives useful as pde4 inhibitors
08/21/2003CA2475703A1 Aryl ureas with angiogenesis inhibiting activity
08/21/2003CA2475545A1 Use of anethole dithiolethione in lung cancer chemoprevention
08/21/2003CA2475522A1 Method of radio-labelling biomolecules
08/21/2003CA2475439A1 Novel pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same
08/21/2003CA2475102A1 Stabilized synthetic immunogen delivery systems
08/21/2003CA2474844A1 Cks1 inhibitors
08/21/2003CA2474405A1 Medicament for the treatment of choroidal neovascularisation
08/21/2003CA2474171A1 Biphenil derivatives and their use as antiandrogenic agents
08/21/2003CA2472822A1 Chemical compounds
08/21/2003CA2452854A1 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/21/2003CA2372785A1 Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors
08/20/2003EP1336600A2 Dimer-selective RXR modulators and methods for their use
08/20/2003EP1335937A2 Mixed fibrils
08/20/2003EP1335935A1 Periplasmic domain of an enterobacterium omp protein and its use as carrier or adjuvant
08/20/2003EP1335933A2 Pna analogues
08/20/2003EP1335924A2 Ethers of 7-desmethylrapamycin for use in immunosuppression
08/20/2003EP1335923A2 Condensed pyridoindole derivatives
08/20/2003EP1335922A1 Novel 4'-demethyl-4'-o-substituted-1-deoxypodophyllotoxin derivative and geometric isomer thereof, process for the preparation thereof and anti-cancer composition comprising the same
08/20/2003EP1335921A1 Novel photosensitizers of 9-hydroxypheophorbide-a derivatives used for photocynamic therapy
08/20/2003EP1335920A2 Small molecule compositions for binding to hsp90
08/20/2003EP1335917A2 Condensed pyridoindole derivatives
08/20/2003EP1335898A1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
08/20/2003EP1335746A2 Recombined anti-gpiib/iiia antibodies used for inhibiting angiogenesis
08/20/2003EP1335745A1 Use of a compound antagonist of the esm-1 protein for producing a medicine for treating cancer
08/20/2003EP1335744A2 Sdf-1 beta expressing tumor cells as tumor vaccines
08/20/2003EP1335738A2 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants
08/20/2003EP1335737A2 Method for optimally delivering virus to a solid tumor mass
08/20/2003EP1335726A1 Modified prodrug forms of ap/amp
08/20/2003EP1335725A2 Use of cci-779 as an antineoplastic agent
08/20/2003EP1335706A2 Microspheres of pancreatic enzymes with high stability
08/20/2003EP1212327B1 Pyrazolopyrimidines as therapeutic agents
08/20/2003EP1212326A4 PYRROLO 2,3-d]PYRIMIDINE NUCLEOSIDE ANALOGS
08/20/2003EP1189908B1 Indolocarbazole alkaloids from a marine actinomycete
08/20/2003EP1165566B1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
08/20/2003EP1146892B1 Baff, inhibitors thereof and their use in the modulation of the b-cell response
08/20/2003EP1143968B1 Composition and methods for administration of water-insoluble paclitaxel derivatives
08/20/2003EP1093381B1 Antigenic peptides derived from telomerase
08/20/2003EP1086106B1 Furopyridine derivatives and their therapeutical use
08/20/2003EP1075489B1 Water-soluble prodrugs of 2,6-diisopropylphenol analogues
08/20/2003EP1053233B1 Hydroxamic and carboxylic acid derivatives
08/20/2003EP0861091B1 Immunotoxin containing a disulfide-stabilized antibody fragment
08/20/2003EP0831829B1 Heterocyclic ring-fused pyrimidine derivatives
08/20/2003EP0794786B1 The use of inositoltrisphosphate for the preparing of medicaments
08/20/2003EP0721510B1 Anti-cancer gene therapy by modulation of immune or inflammatory response
08/20/2003EP0612248B1 Composition containing cisplatin and topotecan as antitumor agent.
08/20/2003CN1437605A Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
08/20/2003CN1437604A Carbamate and thiocarbamate podophyllotoxin derivatives, preparation method and pharmaceutical compositions containing them
08/20/2003CN1437601A Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer
08/20/2003CN1437594A Substituted bicyclic derivatives for the treatment of abnormal cell growth
08/20/2003CN1437592A Process for producing crystal
08/20/2003CN1437591A Compounds and methods for modulation of estrogen receptors
08/20/2003CN1437585A Method and compositions utilizing quinazolinones
08/20/2003CN1437584A Tricyclic protein kinase inhibitors
08/20/2003CN1437485A Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents
08/20/2003CN1437478A Intrathecal administration of Rituximab for treatment of central nervous system lymphomas
08/20/2003CN1437474A Pharmaceutical compositions comprising acryloyl distamycin derivatives and topoisomerase Ôàáand Ôàí inhibitors
08/20/2003CN1437473A Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites
08/20/2003CN1437468A Halogentated 2-amino-5.6-heptenoic aicd derivatives useful as nitric oxide synthase inhibitors
08/20/2003CN1437466A Methods for pulmonary delivery of interleukin-2
08/20/2003CN1437463A System and method for treating a mucosal surface
08/20/2003CN1436841A Fine rod bundle spore SX-1 separated and cultured from cordyceps and its saparation, culture process and use
08/20/2003CN1436792A Tumor necrosis factor relative cell death inducing ligand extracellular region mutation polypeptide and its prepn and use
08/20/2003CN1436564A Liver cancer treating medicine and its prepn
08/20/2003CN1436561A Externally applied ointment for treating prostatosis and its prepn
08/20/2003CN1436556A Anticancer medicine of snake brain tissue and its prepn
08/20/2003CN1436548A Prepn process of alcohol extracting liquid of common yam bulbil
08/20/2003CN1436535A Nisoldipine capsule composition
08/20/2003CN1436534A Megestrol acetate capsule composition
08/20/2003CN1436533A Application of acetyl boswellic acid in preparing antitumor agent
08/20/2003CN1436528A Anticancer medicine composition of citrus multimethoxy flavone and its prepn
08/20/2003CN1436475A Cancer-resisting wild buckwheat root bagged tea
08/20/2003CN1118573C Non-splicing variants of gp 350/220
08/20/2003CN1118475C Cyclopeptide derivatives
08/20/2003CN1118451C Acylated derivatives of melatonin and its analogues as medicine
08/20/2003CN1118287C Health-care medicine
08/19/2003WO2003070947A1 Apoptosis promoter and inhibitor interacting with cgi-94 and method of screening the same
08/19/2003US6608203 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
08/19/2003US6608197 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
08/19/2003US6608192 Collections of compounds
08/19/2003US6608182 Human vascular endothelial growth factor 2
08/19/2003US6608174 Of given amino acid sequence; radionuclides; use as scintigraphic imaging agents for visualization of tumors and metastasis
08/19/2003US6608108 Method for treatment of tumors using nordihydroguaiaretic acid derivatives
08/19/2003US6608107 Administering gossypol; kits to treat patients
08/19/2003US6608106 Contacting the cell with an amount of dehydroascorbic acid effective to increase the concentration of ascorbic acid in the cell
08/19/2003US6608105 For therapy and prophylaxis of diseases such as cachexia attributed to cancer or infections, rheumatoid arthritis, inflammatory diseases, osteoarthritis, systemic lupus erythematosus, rejection during bone marrow transplantation
08/19/2003US6608104 Gem substituted hydroxamic acids
08/19/2003US6608103 Inhibitor for neovasculation, cell multiplication, lumen formation and FGF
08/19/2003US6608099 Indole sPLA2 inhibitors
08/19/2003US6608092 Crystals of benzimidazole compounds
08/19/2003US6608089 Derivatives of flavones, xanthones and coumarins
08/19/2003US6608076 Treating topoisomerase I inhibitor-related disease in mammals
08/19/2003US6608071 Angiogenesis inhibitors as antitumor agents
08/19/2003US6608069 Phenyl xanthine derivatives
08/19/2003US6608068 Substituted indoline derivative compounds which are antagonists of the progesterone receptor; contraceptives; antineoplastic agents
08/19/2003US6608066 Tissue factor antagonists and methods of use thereof
1 ... 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 ... 2211